Similarly, its homolog CAV1 promoted PAH progression by impairing endothelial cell proliferation and migration, reducing cytoskeletal stress fibers, and stimulating neointima formation (Han et al., 2016; Gairhe et al., 2021). The gene discussed is CAV1; the disease is pulmonary arterial hypertension.